Questcor Pharmaceuticals Incorporated
Irish firm to buy fast-growing MS-drug maker Questcor for $5.6 billion

Irish pharmaceutical company Mallinckrodt will pay $5.6 billion in cash and stock for Anaheim-based Questcor Pharmaceuticals Inc., a fast-growing bio-pharmaceutical firm that specializes in treating multiple sclerosis, the companies announced Monday. Under the terms of the deal, Questcor shareholders will be paid $30 a share in cash and 0.897 of a share of Mallinckrodt stock for each share of Questcor common stock they own.  If the deal is approved, Mallinckrodt shareholders will own nearly 51% of the combined company; former Questcor shareholders will own the remaining stake.  The merger "will substantially increase the scale, diversification, cash flow and...